This assay is to provide E.G7-OVA-based In Vitro TRAP Assay (Senescence) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
E.G7-OVA
Target Cell Organism
Mouse
Target Cell Background
E.G7-OVA [derivative of EL4] T lymphoblasts are T lymphoblasts derived in 1988 from the C57BL/6 (H-2 b) mouse lymphoma cell line EL4. E.G7-OVA [derivative of EL4] is a model system for studying major histocompatibility complex (MHC) class I restricted responses of cytotoxic T lymphocytes in mice.
Related Diseases
Lymphoma
Research Area
Oncology
Assay Name
In Vitro TRAP Assay (Senescence)
Assay Description
The telomerase repeated amplification protocol (TRAP) assay is one of the common PCR-based assays used to detect telomerase activity in cells.
Assay Alternative Names
Telomerase Repeated Amplification Protocol Assay
Assay Type
Cellular Senescence in Cancer Assays
Assay Type Details
Cell senescence is described as an irreversible physiological event of cell growth arrest, which is known to be caused by alterations of telomeres, oxidative stress, DNA damage and some oncogenes. Inhibition of the program of senescence is one of the main features of tumor cells and it has been reported that cancer cells can be induced to undergo senescence by chemo- and radiotherapies and genetic alterations. Telomeres help to prevent uncontrolled cell proliferation and the absence of telomeres results in aneuploidy and cell death.